Liu, R., Shi, L., Peng, N., Zhang, Q., & Li, H. (2019). Higher Baseline Serum Irisin Decreases Risk for Body Mass Index Increment in Chinese Populations: A 3.2-Year Cohort Study. Diabetes Ther.
Chicago Style citaatLiu, Ruoyi, Lixin Shi, Nianchun Peng, Qiao Zhang, en Hong Li. "Higher Baseline Serum Irisin Decreases Risk for Body Mass Index Increment in Chinese Populations: A 3.2-Year Cohort Study." Diabetes Ther 2019.
MLA citatieLiu, Ruoyi, et al. "Higher Baseline Serum Irisin Decreases Risk for Body Mass Index Increment in Chinese Populations: A 3.2-Year Cohort Study." Diabetes Ther 2019.
Let op: Deze citaties zijn niet altijd 100% accuraat.